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1. Introduction
Urinary tract infections (UTIs), including cystitis and 
pyelonephritis, are among the most common infections in 
humans, primarily caused by uropathogenic Escherichia 
coli (UPEC) (1,2). The severity of the infection varies 
depending on the virulence of the infecting bacteria and 
host susceptibility (3–5). Urinary tract infections often 
occur in patients with anatomically and functionally normal 
urinary tracts (3). In ascending infections, colonization 
of microorganisms in the urethra leads to the upward 
spread of bacteria to the kidneys (causing pyelonephritis) 
or bladder (causing cystitis) (2,6). Antibiotic resistance is 
another serious problem in infections caused by UPEC. 
Extended-spectrum beta-lactamases (ESBL) are enzymes 
that confer resistance to most beta-lactam antibiotics, 
including penicillins, cephalosporins, and aztreonam (7). 
The high antimicrobial resistance of UPEC associated with 
ESBL production significantly reduces the therapeutic 
options and increases the treatment costs and mortality 
rates (8–10). ESBL-producing UPEC strains, which are 
increasing in prevalence worldwide, have an appreciable 
deleterious impact on the clinical management of UTIs (11). 
UPEC strains harbor a great number of genes that encode 
different virulence factors, which contribute to greater 
pathogenicity (11,12). Virulence factors of UPEC strains 
have a significant role in the development of UTIs (13). The 
molecular features and functions of these virulence factors 
have been determined (1,14). The most likely theory is that 
UPEC primarily germinate from nonpathogenic strains by 
acquiring new virulence genes (through DNA horizontal 
transfer of plasmids, bacteriophages, transposons, and 
pathogenicity islands located at chromosomal loci), which 
confer an increased ability to adapt to new niches and 
allow the bacteria to increase the ability to cause a broad 
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spectrum of diseases (3,15). The dominant virulence 
factors facilitate colonization and invasion of the bacteria 
in sites such as the urethra, as well as the toxin that affects 
the host cells (16,17). The UPEC strains possess adherence 
and virulence factors on the surface called pili or fimbriae, 
which mediate the attachment to uroepithelial cells and 
successfully initiate infections (18). Specific attachment 
is facilitated by bacterial proteins called adhesins, which 
may be associated with fimbriae (19). The pyelonephritis-
associated pilus (Pap) operon is the most commonly found, 
encoding P fimbriae (20). As the main attachment factors, 
P fimbriae are essentially associated with pyelonephritis 
infection (2). The papC gene, located on the pap operon, 
is among the most important virulence genes associated 
with adhesion in UPEC strains (21). Another virulence 
factor associated with adhesion that has important roles 
in the development of UTIs is FimH (adhesive subunit of 
type 1 fimbriae) (13). FimH is a mannose-specific adhesin 
located on the tip of type 1 fimbriae of Escherichia coli and 
is capable of mediating shear-enhanced bacterial adhesion. 
Among adhesins of UPEC, FimH is a major determinant 
that has a high tropism for urinary tract receptors; 
thus, adhesion factor FimH is important in colonizing 
different niches of UPEC isolates (13,22). Besides bacterial 
adherence, several virulence factors may contribute to the 
pathogenicity of UPEC strains, including the production 
of hemolysin toxin (15). A-hemolysin (HlyA) is the most 
significant secretory virulence factor, which is encoded 
by the hly gene (18). The characterization of virulence 
genes can be useful to improve our understanding of the 
pathogenesis of UTIs and to minimize the complications, 
including kidney failure. Few studies have been conducted 
to detect the prevalence of virulence genes in UPEC strains 
causing distinct types of UTIs in our region. Therefore, the 
present study was proposed to determine the frequency 
of important virulence genes as well as the patterns of 
antibiotic resistance and ESBL production in UPEC strains 
isolated from patients with cystitis and pyelonephritis in 
Tehran, Iran.
2. Material and methods 
2.1. Study design and bacteria collection
In this study, a total of two hundred nonduplicate E. 
coli strains were isolated from 4650 urine samples of 
patients suffering from UTI symptoms who referred 
to the laboratories of hospitals over a period of 2 years. 
Bacteriological and biochemical tests were performed 
for confirmation of E. coli strains. Samples with over 
100,000 Cfu/ml E. coli count from clean-voided urine were 
defined as positive UTI infections. Cytobacteriological 
examination of urine specimens was the basis for the 
diagnosis of cystitis and pyelonephritis among patients.
2.2. Antibacterial susceptibility testing
The antibiotic susceptibility of E. coli was determined using 
the Kirby–Bauer disk diffusion method on Muller Hinton 
agar medium with cefotaxime (30 µg), ceftazidime (30 µg), 
nalidixic acid (30 µg), trimethoprim-sulfamethoxazole 
(12.5/23.75 µg), amikacin (30 µg), ciprofloxacin (5 µg), 
gentamicin (10 µg), and nitrofurantoin (30 µg). The 
obtained results of the tests were interpreted according to 
the guidelines of the Clinical Laboratory Standards Institute 
(23). E. coli ATCC 25922 and Klebsiella pneumoniae ATCC 
700603 strains were used as negative and positive controls, 
respectively.
2.3. Determination of extended-spectrum beta-lacta-
mase phenotype
The presence of the beta-lactamase phenotype was 
determined by combination disk diffusion method (24). 
Based on this test, after the inoculation of bacteria in 
standard concentrations on Muller Hinton agar medium, 
a disk of ceftazidime (30 µg) alone and a combination 
disk containing ceftazidime and clavulanic acid (30 
µg/10 µg) were placed at a distance of 25 mm from each 
other. Increase in the size of inhibition zone around the 
combination disk compared to the ceftazidime disk alone 
equal to or above 5 mm was considered as positive ESBL 
phenotype.
2.4. DNA extraction and PCR assay
The colonies of E. coli strains grown on agar medium 
were suspended in TE buffer and total genomic DNA 
for amplification was purified from whole cells by simple 
boiling method (25). The purity and integrity of extracted 
DNA was confirmed by electrophoresis and biophotometer 
analysis, respectively. The PCR amplification was 
performed for the investigation of three types of virulence 
genes including papC, fimH, and hlyA with specific 
primers as labeled in Table 1. The PCR products were 
electrophoresed on agarose gel and visualized by gel 
documentation after ethidium bromide staining.
2.5. Statistical analysis 
Statistical analysis was performed using SPSS 16.0 (SPSS 
Inc., Chicago, IL, USA). Correlation between variables was 
evaluated by chi-square test. P < 0.05 was considered as 
statistically significant.
3. Results 
A total of 200 E. coli isolates were recovered from urine 
samples with a count of more than 105  cfu/mL during 
2015–2017. Frequency of E. coli isolation was higher in 
females (86%) than males (14%). Ages of the patients 
suffering from UTIs ranged between 1 and 91 years. The 
median age was 38 ± 22.7 years. The number of E. coli 
isolates recovered from inpatient and outpatients was 40 
(20%) and 160 (80%), respectively. Among the 200 E. coli 
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strains, 72 (36%) strains revealed the ESBL phenotype. Of 
72 positive ESBL strains, 24 (12%) and 48 (24%) strains 
were isolated from pyelonephritis and cystitis cases, 
respectively. PCR products of three virulence genes were 
analyzed on agarose gel (Figure). Results showed that the 
frequency of the studied virulence genes including papC, 
fimH, and hlyA were 38%, 64%, and 12%, respectively. The 
frequency of carrying any of these three virulence genes 
alone was 32% for fimH, 4% for hlyA, and 4% for papC. 
The fimH gene was the most common virulence gene and 
was detected in 64% of patients, which further revealed 
that the prevalence was higher in cystitis cases (65.3%). 
Twenty-four percent of isolates were negative for these 
three virulence genes (Table 2). The majority of virulence 
genes were detected in ESBL and non-ESBL isolates and 
in outpatients and inpatients. The hlyA, papC, and fimH 
genes were respectively present in 10 (31.25%), 15 (46.8%), 
and 21 (65.6%) of strains isolated from inpatients and 16 
(9.5%), 62 (36.9%), and 108 (64.2%) of strains collected 
from outpatients. The incidences of fimH, papC, and hlyA 
virulence genes were higher in inpatients compared to 
outpatients. There was a significant difference between 
ESBL-positive and -negative groups for carrying the three 
virulence genes (P < 0.005). The virulence genes were 
most frequently detected in patients with ESBL-positive 
strains and the fimH gene was the most prevalent. The 
composition of the virulence genes was similar in both 
sexes. The prevalence of virulence genes was higher 
in patients over 50 years of age (Table 3). Multidrug 
resistance was detected by antibiotic susceptibility test. 
Of the 200 isolates, 128 (64%) were multidrug-resistant. 
In ESBL-producing E. coli strains, 100% of strains had 
Table 1. Primer sequences of studied virulence genes in E. coli isolates.
Primer Oligonucleotides Product size Reference
papC F: GTGGCAGTATGAGTAATGACCGTTAR: ATATCCTTTCTGCAGGGATGCAATA 200 bp (39)
fimH F: TGCAGAACGGATAAGCCGTGGR: GCAGTCACCTGCCCTCCGGTA 508 bp (39)
hlyA F: AACAAGGATAAGCACTGTTCTGGCTR: ACCATATAAGCGGTCATTCCCGTCA 1177 bp (39)
F: Forward primer, R: reverse primer.
Figure. Gel electrophoresis of PCR products. A) PCR products of hlyA gene (1117 bp), B) PCR products 
of fimH gene (500 bp), C) PCR products of papC gene (200 bp).
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multidrug resistance, while in E. coli strains without ESBL 
production 43.75% were multidrug-resistant (P < 0.005) 
(Table 4). There was a significant difference in antibiotic 
resistance between patients suffering from pyelonephritis 
and cystitis (P < 0.001). 
4. Discussion
UTIs caused by uropathogenic Escherichia coli are among 
the most important infectious diseases leading to renal 
failure (26). The degree of pathogenicity of UPEC strains is 
dependent upon the existence of virulence genes (27,28). 
Pyelonephritis-associated pilus (pap) is an important 
factor in the pathogenesis of UTIs, and the essential role of 
P fimbriae in the progress of pyelonephritis is well known 
(2,29). The frequency of papC in our study was 38%. The 
study of López-Banda et al. also reported a high frequency 
of the papC gene (62%) in UPEC strains (21). The frequency 
of the papC gene in UPEC isolates in the present study 
was similar to those found in Iran, Brazil, Tunisia, and 
China (6,8,30,31). The high prevalence of the papC gene 
suggests that these strains have the ability to colonize the 
kidneys and generate pyelonephritis. Our study showed 
that the frequency of the papC gene between patients with 
cystitis (36.6%) and pyelonephritis (36%) was similar. Our 
findings are in disagreement with the results reported by 
Firoozeh et al. (2) and Mabbett et al. (32), showing the pap 
gene to be significantly more prevalent among patients 
with pyelonephritis than cystitis. hlyA (α-hemolysin) has 
been associated with clinical severity in UTI patients (33). 
In our study, hlyA was detected in 12% of UPEC strains. 
Jalali et al. (3) showed a higher frequency of the hlyA 
gene (47%), while López-Banda et al. (21) indicated a 
lower prevalence of this gene (7.4%) in UPEC strains. Our 
results showed a higher prevalence of the hlyA gene among 
UPEC isolates causing cystitis (10.6%) in comparison to 
the isolates causing pyelonephritis (16%), while, in the 
study of Firoozeh et al. (2), the frequency of hlyA was 
1.3% and 6.9% in cystitis and pyelonephritis isolates, 
Table 2. Different patterns of virulence factors among UPEC 
isolates.
Pattern Rate





































hlyA 9.52% 25% 4.1% 7.1% 10.6% 16% 11.1% 12.79%
fimH 62.5% 64.28% 30.5% 32.8% 65.3% 60% 65.11% 57.14%
papC 43.75% 36.90% 20.8% 17.96% 36.6% 36% 21.4% 40.69%
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respectively. These findings show that the prevalence of 
these genes possibly varies based on geographical region. 
fimH, the adhesive subunit of type 1 fimbriae, was the most 
prevalent virulence factor detected in UPEC strains. Also, 
in agreement with our observation, Yun et al. (33), Jalali 
et al. (3), Qin et al. (6), Tarchouna et al. (30), Tajbakhsh 
et al. (34), and Wang et al. (35) found the fimH gene to be 
the most prevalent virulence factor among UPEC strains. 
In the study of Qin et al. (6), among 70 UPEC strains 
fimH was detected in 82% and 88% of pyelonephritis and 
cystitis specimens, respectively. Consistently, our findings 
indicated that this prevalence was 60% and 65.3% in 
pyelonephritis and cystitis specimens, respectively.
Our results showed that the prevalence of hlyA, papC, 
and fimH genes in strains isolated from inpatients were 
31.25%, 46.8%, and 65.6%, respectively, and in strains 
collected from outpatients were 9.5%, 36.9%, and 64.2%, 
respectively. In comparison to our findings, Santo et 
al. (36) showed a similar frequency of hlyA (32%) but 
no similar prevalence of pap (9%) and fimH (5%) was 
reported in inpatient UPEC isolates; on the other hand, 
a similar rate of pap (23%) and conflicting rates of hlyA 
(64%) and fimH (20%) were observed in outpatients. Santo 
et al. (36) illustrated that strains isolated from outpatients 
displayed a greater number of virulence factors compared 
to those from hospitalized subjects, in disagreement with 
our results showing a higher frequency of fimH, papC, and 
hlyA virulence genes in inpatients compared to outpatients. 
In the study of Hojati et al. (13), from 130 fimH-positive 
isolates, 47.7% and 52.3% belonged to inpatients and 
outpatients, respectively, in agreement with our findings 
representing a high prevalence of fimH in inpatient and 
outpatient UPEC isolates. Mohajeri et al. (19) showed that 
the frequency of the pap gene in inpatient and outpatient 
subjects was 18.3% and 21.6%, respectively, which was 
meaningfully lower than our results of the frequency of 
this gene in inpatient and outpatient groups. Mohajeri et 
al. (19) also indicated that the prevalence of the hemolysin 
gene was 18.3% and 32.1% in inpatient and outpatient 
subjects, respectively, contrary to our study indicating a 
higher frequency of hlyA gene in inpatients compared to 
outpatients.
In our study, out of 200 UPEC strains, 36% were 
ESBL-positive and 64% were ESBL-negative. Similar to 
our results, Tabar et al. (37) reported that 26.6% of UPEC 
strains harbored ESBL-associated genes. Among these 
isolates, 128 (64%) strains were multidrug-resistant. Tabasi 
et al. (14) found that 26.9% of UPEC strains were ESBL 
producers and totally 79% of all isolates were multidrug-
resistant, similar to our results for ESBL production and 
multidrug resistance status among UPEC strains. Tabasi 
et al. (14) also showed that antibiotic resistance occurred 
at a higher rate among ESBL-producing isolates compared 
to non-ESBL-producing strains for all tested antibiotics, 
consistent with our results illustrating a higher rate 
of resistance to different antibiotics in ESBL-positive 
compared to ESBL-negative strains. In the study of Qin et 
al. (6), 53% of UPEC isolates produced ESBL. On the other 
hand, Qi et al. (38) reported that 2.9% of UPEC strains 
recovered from outpatient urine cultures harbored ESBLs, 
while in our study a higher number of UPEC strains 
collected from outpatients harbored ESBL enzymes. Qin et 
al. (6) declared that, among all studied virulence genes, the 
fimH gene had the highest frequency in ESBL-producing 
(76%) and non-ESBL-producing (97%) UPEC strains, in 
agreement with the present research indicating the fimH 
gene as the most frequent virulence gene detected in 
ESBL-producing and non-ESBL-producing UPEC isolates. 
However, the frequency of this gene was higher in ESBL-
positive than ESBL-negative strains in our study.
Our study on UPEC strains isolated from pyelonephritis 
and cystitis was meant as a step towards improving the 
knowledge regarding their virulence gene determinants 
and the ability to deal with them. In conclusion, in 
our patients, we found no significant differences in 
pyelonephritis-causing UPEC strains and cystitis-causing 
UPEC strains in the presence of the studied virulence 
genes, but the frequencies of hlyA and papC were higher 
among UPEC strains isolated from inpatients compared 
to outpatients; hence, they could be considered as useful 
targets for prophylactic interventions. These findings raise 
the possibility that the increase in virulence genes may 
lead to the higher risk of severe diseases in inpatients. On 
the other hand, our results indicated that about 64% of 
UPEC isolates harbored the fimH gene. The high binding 
ability of fimH could result in the increased pathogenicity 
of UPEC strains; thus, this gene could be used as a possible 
diagnostic marker and/or vaccine candidate. Also, in the 
current study, higher resistance was observed in ESBL-
producing strains than non-ESBL-producing strains; 
therefore, empiric treatment regimens have to be modified 
against ESBL enzymes to reach better therapeutic 
outcomes.
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